Skip to main content
Clean Science and Technology Limited logo

Clean Science and Technology Limited — Investor Relations & Filings

Ticker · CLEAN ISIN · INE227W01023 LEI · 335800ONLA5LRUZJZB84 BSE.NS Manufacturing
Filings indexed 474 across all filing types
Latest filing 2026-05-14 Regulatory Filings
Country IN India
Listing BSE.NS CLEAN

About Clean Science and Technology Limited

https://cleanscience.co.in/

Clean Science and Technology Limited specializes in the development and manufacture of specialty chemicals using sustainable and eco-friendly catalytic processes. The company focuses on green chemistry to produce high-purity performance chemicals, pharmaceutical intermediates, and FMCG ingredients. Key products include Monomethyl Ether of Hydroquinone (MEHQ), Butylated Hydroxyanisole (BHA), Ascorbyl Palmitate, Guaiacol, and 4-Methoxy Acetophenone (4-MAP). These products serve diverse global applications in the food, pharmaceutical, and personal care sectors. The company leverages proprietary technology and atom-efficient manufacturing routes to minimize waste and environmental impact, establishing itself as a global leader in several niche chemical segments through cost-effective and innovative production methodologies.

Recent filings

Filing Released Lang Actions
Enclosed are the details of Dividend
Regulatory Filings Classification · 85% confidence The document is a formal SEBI Listing Regulations announcement to BSE and NSE describing the outcome of the Board meeting, approval of audited standalone and consolidated financial results, auditor’s report attachment, dividend recommendation and auditor re-appointments. It does not itself contain detailed financial tables or substantive period analysis, nor is it purely a dividend or management change notice. It is a compliance filing under SEBI (Listing Obligations and Disclosure Requirements) and serves as a general regulatory disclosure. This fits the fallback “Regulatory Filings” category (RNS).
2026-05-14 English
Board considered dividend of Rs.4/- per share
Report Publication Announcement Classification · 85% confidence The document is a formal SEBI listing regulation filing announcing the outcome of a board meeting held on 14 May 2026, specifically notifying that the audited standalone and consolidated financial results for Q4 and FY ended 31 March 2026 have been approved and are enclosed, along with the auditor’s report. It is not the full annual report or financial statements itself, but an announcement that those results and the auditor’s report have been published/attached. Therefore, it aligns with the “Report Publication Announcement” category rather than being the actual financial report or earnings release.
2026-05-14 English
General Updates
Earnings Release Classification · 83% confidence The document is an official exchange filing under SEBI LODR, reporting the outcome of a Board meeting held on May 14, 2026, in which the audited standalone and consolidated financial results for the quarter and full year ended March 31, 2026 were approved and recommended for dividend. This is the initial public announcement of the periodical financial results (including key highlights and audited numbers) rather than the full annual report narrative. Thus, it aligns with an Earnings Release rather than a full 10-K, IR (interim report), or a simple notice of report publication. It is not a management or governance paper, M&A, financing, or dividends-only notice, so it best fits the definition of an Earnings Release. FY 2026
2026-05-14 English
Dividend
Interim / Quarterly Report Classification · 85% confidence The document is a Board Meeting outcome filed under SEBI LODR Regulations 30 & 33, enclosing the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026 along with the auditor’s report and detailed financial statements. This is not merely a brief earnings announcement (ER) or a report publication notice (RPA); it contains substantive financial data and audited statements, consistent with a comprehensive financial report. Therefore, it should be classified as an Interim / Quarterly Report (IR). FY 2026
2026-05-14 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 68% confidence The document is a formal regulatory disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, announcing and enclosing the Company’s audited standalone and consolidated financial results for the fourth quarter and full year ended March 31, 2026 along with the auditor’s report. It contains actual financial statements and the independent audit report, not merely key highlights (so it’s more than an earnings release) and is not a full annual report (“10-K”), but rather a periodic financial report for the quarter (with year-end results) submitted to the stock exchanges. This aligns with our ‘Interim / Quarterly Report (IR)’ category, which covers comprehensive financial reports for periods shorter than a full fiscal year that include substantive financial data and statements. FY 2026
2026-05-14 English
Enclosed are the Results
Audit Report / Information Classification · 85% confidence The document is a formal stock‐exchange filing under SEBI Listing Regulations announcing the outcome of a Board meeting, including the approval of audited standalone and consolidated financial results and enclosing the full Independent Auditor’s Report with unmodified opinion. It is not a brief earnings highlight (ER) nor a simple publication notice (RPA), but contains the full audit opinion and related audit information. Thus it best fits the Audit Report / Information category. FY 2026
2026-05-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.